Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
G1 Therapeutics
Biotech
EQRx abandons low cost drug plan, cuts programs and staff
EQRx is abandoning its plan to provide drugs that are typically expensive at lower prices, cutting programs and laying off staff.
Gabrielle Masson
May 8, 2023 7:19pm
G1 sheds staff while Sorrento WARNs of layoffs
Mar 1, 2023 2:02pm
GSK's ex-vaccine, pharma lead jumps ship to run G1
Oct 2, 2020 8:30am
G1 Therapeutics' chemo companion nabs speedy FDA review
Aug 17, 2020 10:40am
EQRx bags rights to EGFR inhibitor to drive discount me-too plan
Jul 23, 2020 9:00am
G1 hits significant increase in breast cancer survival
Sep 28, 2019 5:15am